Wang Niansong
Abstract
Biological agents for the treatment of rheumatic diseases have made a major breakthrough over the past decade.Since the discovery of adalimumab,a tumor necrosis factor(TNF)-α inhibitor,the rheumatoid arthritis therapy has been made significant progress.This article reviews related progress in the treatment of rheumatoid arthritis with adalimumab.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Biological agents for the treatment of rheumatic diseases have made a major breakthrough over the past decade.Since the discovery of adalimumab,a tumor necrosis factor(TNF)-α inhibitor,the rheumatoid arthritis therapy has been made significant progress.This article reviews related progress in the treatment of rheumatoid arthritis with adalimumab.
Key concepts: Adalimumab, Medicine, Rheumatoid arthritis, Tumor necrosis factor alpha, Antirheumatic Agents, Infliximab, Tumor necrosis factor α, Immunology